We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Lesaka Technologies
LSAK
$420M
| $2.59M | 0.02% |
189,216
+12,433
| +7% | +$162K |
|
|
FPO
552
DELISTED
First Potomac Realty Trust
FPO
| $2.58M | 0.02% |
217,151
-145,024
| -40% | -$1.78M |
|
|
HME
553
DELISTED
HOME PROPERTIES, INC
HME
| $2.57M | 0.02% |
37,057
+31,153
| +528% | +$2.16M |
|
554
United Microelectronic
UMC
$46.9B
| $2.56M | 0.02% |
1,048,249
-1,625,733
| -61% | -$3.97M |
|
555
Philips
PHG
$26.1B
| $2.55M | 0.02% |
129,876
+73,399
| +130% | +$1.46M |
|
|
XCRA
556
DELISTED
Xcerra Corporation
XCRA
| $2.55M | 0.02% |
286,631
+101,127
| +55% | +$870K |
|
557
MaxLinear
MXL
$6.8B
| $2.54M | 0.02% |
312,365
+86,667
| +38% | +$713K |
|
558
Honeywell
HON
$78B
| $2.53M | 0.02% |
+27,029
| New | +$2.47M |
|
559
PDF Solutions
PDFS
$2.07B
| $2.53M | 0.02% |
141,171
+56,595
| +67% | +$984K |
|
|
NXGN
560
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $2.51M | 0.02% |
157,052
-12,270
| -7% | -$203K |
|
|
CRESY
561
Cresud
CRESY
$773M
| $2.49M | 0.02% |
203,348
+5,861
| +3% | +$61.8K |
|
562
Weis Markets
WMK
$1.86B
| $2.47M | 0.02% |
49,652
| – | – |
|
563
McCormick & Company Non-Voting
MKC
$14.2B
| $2.47M | 0.02% |
+63,954
| New | +$2.37M |
|
564
Federated Hermes
FHI
$4.72B
| $2.46M | 0.02% |
72,738
+51,452
| +242% | +$1.71M |
|
565
Nelnet
NNI
$4.7B
| $2.41M | 0.01% |
51,023
| – | – |
|
|
VSTO
566
DELISTED
Vista Outdoor Inc.
VSTO
| $2.41M | 0.01% |
+56,329
| New | +$2.39M |
|
567
Buckle
BKE
$2.37B
| $2.41M | 0.01% |
47,113
+36,673
| +351% | +$1.85M |
|
|
RTEC
568
DELISTED
Rudolph Technologies Inc
RTEC
| $2.38M | 0.01% |
215,925
+53,724
| +33% | +$614K |
|
|
WPG
569
DELISTED
Washington Prime Group Inc.
WPG
| $2.38M | 0.01% |
15,878
-130,404
| -89% | -$20.2M |
|
570
Harte-Hanks
HHS
| $2.37M | 0.01% |
30,330
+12,492
| +70% | +$966K |
|
571
Vodafone
VOD
$37.4B
| $2.36M | 0.01% |
72,300
-943,249
| -93% | -$32.4M |
|
|
COHR
572
DELISTED
Coherent Inc
COHR
| $2.33M | 0.01% |
35,834
+6,268
| +21% | +$391K |
|
573
Acco Brands
ACCO
$407M
| $2.32M | 0.01% |
279,457
-102,516
| -27% | -$814K |
|
|
ARGO
574
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $2.32M | 0.01% |
58,499
+7,463
| +15% | +$290K |
|
|
ABAX
575
DELISTED
Abaxis Inc
ABAX
| $2.32M | 0.01% |
36,172
-13,826
| -28% | -$842K |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.